Quarterly Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7312808

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
9,157,000,000 JPY
11,372,000,000 JPY
Interest and dividends received
398,000,000 JPY
342,000,000 JPY
Interest paid
-19,000,000 JPY
-13,000,000 JPY
Income taxes paid
-4,013,000,000 JPY
-4,455,000,000 JPY
Net cash provided by (used in) operating activities
5,522,000,000 JPY
7,246,000,000 JPY
Cash flows from investing activities
Purchase of securities
-2,000,000,000 JPY
-2,000,000,000 JPY
Purchase of property, plant and equipment
-21,729,000,000 JPY
-7,624,000,000 JPY
Proceeds from sale of property, plant and equipment
3,000,000 JPY
2,000,000 JPY
Purchase of investment securities
-5,000,000 JPY
-205,000,000 JPY
Other, net
-82,000,000 JPY
-111,000,000 JPY
Net cash provided by (used in) investing activities
-14,879,000,000 JPY
-8,083,000,000 JPY
Cash flows from financing activities
Dividends paid
-4,310,000,000 JPY
-3,950,000,000 JPY
Other, net
-127,000,000 JPY
-110,000,000 JPY
Net cash provided by (used in) financing activities
-4,438,000,000 JPY
-4,061,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,276,000,000 JPY
1,003,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-12,518,000,000 JPY
-3,894,000,000 JPY
Cash and cash equivalents
47,172,000,000 JPY
59,690,000,000 JPY
75,586,000,000 JPY
79,480,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.